Literature DB >> 11852912

Technology as a 'major driver' of health care costs: a cointegration analysis of the Newhouse conjecture.

Albert A Okunad1, Vasudeva N R Murthy.   

Abstract

Per capita real income on the demand-side and technological change, proxied by total R&D and health R&D spending, on the supply-side are hypothesized as major drivers of per capita real health care expenditure in the US during the 1960-1997 period. The findings are robust to a battery of unit root and cointegration tests. They support the Newhouse [Journal of Economic Perspectives 6 (1992) 3] conjecture that technological change is a major escalator of health care expenditure and confirm a significant and stable long-run relationship among per capita real health care expenditure, per capita real income and broad-based R&D expenditures. Policy implications are noted.

Entities:  

Mesh:

Year:  2002        PMID: 11852912     DOI: 10.1016/s0167-6296(01)00122-9

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  38 in total

1.  Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan.

Authors:  Chee-Ruey Hsieh; Ya-Ming Liu; Chia-Lin Chang
Journal:  Eur J Health Econ       Date:  2011-12-27

2.  The convergence of health care financing structures: empirical evidence from OECD-countries.

Authors:  Andrea M Leiter; Engelbert Theurl
Journal:  Eur J Health Econ       Date:  2010-07-18

3.  Determinants of health expenditure growth of the OECD countries: jackknife resampling plan estimates.

Authors:  Albert A Okunade; Mustafa C Karakus; Charles Okeke
Journal:  Health Care Manag Sci       Date:  2004-08

4.  Economic evidence at the local level : options for making it more useful.

Authors:  Kees van Gool; Gisselle Gallego; Marion Haas; Rosalie Viney; Jane Hall; Robyn Ward
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

5.  The effect of pharmaceutical patent term length on research and development and drug expenditures in Canada.

Authors:  Paul Grootendorst; Livio Di Matteo
Journal:  Healthc Policy       Date:  2007-02

6.  Measuring US pharmaceutical industry R&D spending.

Authors:  Joseph Golec; John Vernon
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

7.  Controlling the US health care system with policy wedges.

Authors:  George W Pasdirtz
Journal:  Health Care Manag Sci       Date:  2007-12

8.  Health expenses and economic growth: convergence dynamics across the Indian States.

Authors:  Nicholas Apergis; Puja Padhi
Journal:  Int J Health Care Finance Econ       Date:  2013-09-14

9.  The missing technology: an international comparison of human capital investment in healthcare.

Authors:  Bianca K Frogner
Journal:  Appl Health Econ Health Policy       Date:  2010       Impact factor: 2.561

10.  Relationship Between Quality of Comorbid Condition Care and Costs for Cancer Survivors.

Authors:  Kevin D Frick; Claire F Snyder; Robert J Herbert; Amanda L Blackford; Bridget A Neville; Antonio C Wolff; Michael A Carducci; Craig C Earle
Journal:  J Oncol Pract       Date:  2016-05-10       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.